De Novo Biosynthesis of 1,5‐Pentanediol by Metabolically Engineered Escherichia coli
Biotechnology and Bioengineering · 2026-05 · 123 (5) · 1166-1180
DOI: 10.1002/bit.70167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 04.02.2026. Verfasst von Chen Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Na…. Hauptthemen laut MEDLINE: Escherichia coli, Metabolic Engineering, Glycols. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Natural Science Foundation of Jiangsu Province, Jiangsu Basic Research Center for Synthetic Biology.
Abstract (Originalsprache)
1,5‐Pentanediol (1,5‐PDO) is a five‐carbon aliphatic diol widely used as a raw material for synthesis of polyurethanes, polyesters, plastics, or fibers. Recently, the de novo synthesis of 1,5‐PDO has been established, but the accumulation of intermediates and low yield of product limit its further application. In this study, based on the l ‐lysine high‐producing Escherichia coli , an efficient microbial cell factory containing a 5‐hydroxyvalerate synthesis module (5‐HV) and a 1,5‐PDO synthesis module was designed. By screening the enzymes of different modules, a 1,5‐PDO‐synthesizing recombinant strain with the best combination of MmCAR, Yahk, and GabT was obtained. The amino acid residues in the adenosine domain of CAR were rationally mutated to glutamic acid to obtain the variant MmCAR Q302E , which had enhanced activity against 5‐HV and reduced its accumulation. Subsequently, the accumulation of 5‐HV was further reduced by enhancing the expression of CAR through RBS engineering and fixing CAR with the help of EutM protein scaffold. In addition, the endogenous gene ycjQ of E. coli was deleted to reduce the reoxidation of 1,5‐PDO. Finally, the 1,5‐PDO yield reached 12.9 g/L under the optimized fermentation conditions, achieving efficient biosynthesis of 1,5‐PDO and lower accumulation of 5‐HV, which is the highest yield reported in E. coli so far.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, Jiangsu, China.
ORCID-Profile: Kequan Chen
Förderung
- National Nature Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Jiangsu Basic Research Center for Synthetic Biology
Zitieren
APA
Ma, C., Qin, L., Hua, W., Wu, Y., Xu, S., Zhao, W., Wang, J., Ma, C., Chen, K., & Wang, X. (2026). De Novo Biosynthesis of 1,5‐Pentanediol by Metabolically Engineered Escherichia coli. Biotechnology and Bioengineering, 123(5), 1166-1180. https://doi.org/10.1002/bit.70167
Vancouver
Ma C, Qin L, Hua W, Wu Y, Xu S, Zhao W, et al. De Novo Biosynthesis of 1,5‐Pentanediol by Metabolically Engineered Escherichia coli. Biotechnology and Bioengineering. 2026;123(5):1166-1180. doi:10.1002/bit.70167
BibTeX
@article{Ma2026,
author = {Ma, Chen and Qin, Lisha and Hua, Wenfeng and Wu, Yifei and Xu, Shuang and Zhao, Wenbin and Wang, Jiali and Ma, Chenxi and Chen, Kequan and Wang, Xin},
title = {De Novo Biosynthesis of 1,5‐Pentanediol by Metabolically Engineered Escherichia coli},
journal = {Biotechnology and Bioengineering},
year = {2026},
volume = {123},
number = {5},
pages = {1166--1180},
doi = {10.1002/bit.70167}
}
EUVIMED